ASCRS Live: Visus Therapeutics shares data from Phase 3 pivotal study, BRIO-I

May 8, 2023

Print

MORE NEWS

January 8, 2024
The Ultimate Guide to Presbyopia Drops
>
Learn more about our latest developments

Visus Therapeutics, Inc.
2 Nickerson St. Ste 101
Seattle, WA 98109

© VISUS THERAPEUTICS 2021 ALL RIGHTS RESERVED
VISUS THERAPEUTICS and BRIMOCHOL are trademarks of Visus Therapeutics, Inc.